The committee’s COVID Money Tracker tool follows aid authorizations from Congress, the Federal Reserve and the Trump administration during the COVID-19 public health and economic crisis.
To date, about $291 billion, or 71 percent of financial support earmarked for the health industry, has been disbursed or committed.
Here’s where some of the money has gone:
Grants to health providers: $117 billion
Accelerated and advance Medicare payments to hospitals: $92 billion
Accelerated and advance Medicare payments to physicians: $8 billion
Moderna vaccine funding: $2 billion
GlaxoSmithKline vaccine funding: $2 billion
Pfizer vaccine funding: $2 billion
Novavax vaccine funding: $2 billion
Johnson & Johnson vaccine funding: $2 billion
AstraZeneca vaccine funding: $1 billion
Regeneron Therapeutic funding: $450 million
To view the full report, click here.
More articles on healthcare finance:
Financial fallout from COVID-19: 38 hospitals laying off workers
CMS threatens to terminate Chicago hospital’s Medicare contract
Hospitals face closure as $100B in Medicare loans come due
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
